SC 13G: ORAGENICS INC

AI Summary

SC 13G filing by ORAGENICS INC.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securitie

Filing Documents

• sch13g.htm (SC 13G) — 61KB
• exhibit99-1.htm (EX-99.1) — 6KB
• 0000929638-24-000934.txt ( ) — 68KB

From the Filing

SC 13G 1 sch13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * Oragenics, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 684023500 (CUSIP Number) March 1, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) ___________________________________ * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1 Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Lind Global Fund II LP 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [x] 3 SEC Use Only 4 Citizenship or Place of Organization. Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 265,000 6 Shared Voting Power 0 7 Sole Dispositive Power 265,000 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned by Each Reporting Person 265,000 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11 Percent of Class Represented by Amount in Row (9)* 5.9% 12 Type of Reporting Person (See Instructions) PN 1 Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Lind Global Partners II LLC 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [x] 3 SEC Use Only 4 Citizenship or Place of Organization. Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 265,000 6 Shared Voting Power 0 7 Sole Dispositive Power 265,000 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned by Each Reporting Person 265,000 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11 Percent of Class Represented by Amount in Row (9)* 5.9% 12 Type of Reporting Person (See Instructions) OO 1 Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Jeff Easton 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [x] 3 SEC Use Only 4 Citizenship or Place of Organization. United States Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 265,000 6 Shared Voting Power 0 7 Sole Dispositive Power 265,000 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned by Each Reporting Person 265,000 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11 Percent of Class Represented by Amount in Row (9)* 5.9% 12 Type of Reporting Person (See Instructions) IN Item 1. (a) Name of Issuer Oragenics, Inc. (b) Address of Issuer's Principal Executive Offices 1990 Main Street Suite 750 Sarasota, FL 34236 Item 2. (a) Name of Person Filing This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): Lind Global Fund II LP, a Delaware limited partnership; Lind Global Partners II LLC, a Delaware limited liability company; and Jeff Easton, an individual and a citizen of the United States of America. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II LP. Jeff Easton, the managing member of Lind Global Partners II LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II LP. (b) Address of Principal Business Office or, if none, Residence The address of the principal business office for each of the Reporting Persons is: 444 Madison Ave, Floor 41 New York, NY 10022 (c) Citizenship See Row 4 of cover page for each Reporting Person. (d) Title of Class of Securities Common Stock, par value $0.001 per share (e) CUSIP Number 684023500 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable. Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficial

View Full Filing

View this SC 13G filing on SEC EDGAR